Lund Vasculitis Epidemiology Research Group
21 – 30 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study
(
- Contribution to journal › Article
-
Mark
Clustering of anti-neutrophil cytoplasmic antibody-associated vasculitis - using a pre-processed harmonised dataset
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
An update on the epidemiology of Behçet’s disease in southern Sweden
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Myocardial infarction in ANCA-associated vasculitis- a population-based cohort-study
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Epidemiology and Clinical Characteristics of Adult-Onset IgA Vasculitis in Southern Sweden
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
- 2021
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
(
- Contribution to journal › Article
-
Mark
Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
High risk of coronary artery aneurysm in Kawasaki disease
(
- Contribution to journal › Article